Regulation of growth of the adrenal gland in DOC-salt hypertension: Role of angiotensin II receptor subtypes

Hypertension

Volumn 29, Issue 1 II, 1997, Pages 408-413

  Elijovich, Fernando ^a,c   Zhao, Hua Wei ^a   Laffer, Cheryl L ^a   Du, Yong ^a   DiPette, Donald J ^a   Inagami, Tadashi ^b   Wang, Donna H ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

blotting, Northern; deoxycorticosterone; gene expression regulation; losartan; ramipril; rats; receptors, angiotensin II

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; DEOXYCORTICOSTERONE; LOSARTAN; RAMIPRIL; RECEPTOR SUBTYPE;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HYPERTENSION; MALE; NONHUMAN; ORGAN GROWTH; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0031017163     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.29.1.408     Document Type: Article

References (45)

1. Lyall F, Dornan ES, McQueen J, Boswell F, Kelly M. Angiotensin II increases proto-oncogene expression and phosphoinositide turnover in vascular smooth muscle cells via the angiotensin II AT1 receptor. J Hypertens. 1992;10:1463-1469.
2. Kojima M, Shiojima I, Yamazaki T, Komuro I, Yunzeng Z, Ying W, Mizuno T, Ueki K, Tobe K, Kadowaki T, Nagai R, Yazaki Y. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. Circulation. 1994;89:2204-2211.
3. Ray PE, Bruggeman DA, Horikoshi S, Aguilera G, Klotman PE. Angiotensin II stimulates human fetal mesangial cell proliferation and fibronectin biosynthesis by binding to AT1 receptors. Kidney Int. 1994;45:177-184.
4. Feener EP, Northrup JM, Aiello LP, King GL. Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J Clin Invest. 1995;95:1353-1362.
5. Janiak P, Libert O, Vilaine JP. Role of the renin-angiotensin system in neointima formation after injury in rabbits. Hypertension. 1994; 24:671-678.
6. Sasaki K, Yamano Y, Bardhan S, Iwai N, Murray JJ, Hasegawa M, Matsuda Y, Inagami T. Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature. 1991;351:230-233.
7. Tsuzuki S, Ichiki T, Nakakubo H, Kitami Y, Guo DF, Shirai H, Inagami T. Molecular cloning and expression of the gene encoding human angiotensin II type 2 receptor. Biochem Biophys Res Commun. 1994;200:1449-1454.
8. Nakajima M, Hutchinson HG, Fujinaga M, Hayashida W, Morishita R, Zhang L, Horiuchi M, Pratt RE, Dzau VJ. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci U S A. 1995;92:10663-10667.
9. Smits GJ, Koepke JP, Blaine EH. Reversal of low-dose angiotensin hypertension by angiotensin receptor antagonists. Hypertension. 1991;18:17-21.
10. Aguilera G. Role of angiotensin II receptor subtypes on the regulation of aldosterone secretion in the adrenal glomerulosa zone in the rat. Mol Cell Endocrinol. 1992;90:53-60.
11. Inagami T, Yamano Y, Bardhan S, Chaki S, Guo DF, Ohyama K, Kambayashi Y, Takahashi K, Ichiki T, Tsuzuki S, Tang H. Cloning, expression and regulation of angiotensin II receptors. Adv Exp Med Biol. 1995;377:311-317.
12. Levy BI, Benessiano J, Henrion D, Caputo L, Heymes C, Duriez M, Poitevin P, Samuel JL. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J Clin Invest. 1996;98:418-425.
13. Janiak P, Pillon A, Prost JF, Vilaine JP. Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension. 1992:20:737-745.
14. Song K, Kurobe Y, Kanehara H, Okunishi H, Wada T, Inada Y, Nishikawa K, Miyazaki M. Quantitative localization of angiotensin II receptor subtypes in spontaneously hypertensive rats. Blood Press Suppl. 1994;5:21-26.
15. Shanmugam S, Llorens-Cortes C, Clauser E, Corvol P, Gasc JM. Expression of angiotensin II AT2 receptor mRNA during development of rat kidney and adrenal gland. Am J Physiol. 1995;268: F922-F930.
16. Natarajan R, Gonzalez N, Hornsby PJ, Nadler J. Mechanism of angiotensin II-induced proliferation in bovine adrenocortical cells. Endocrinology. 1992;131:1174-1180.
17. Tian Y, Balla T, Baukal AJ, Catt KJ. Growth responses to angiotensin II in bovine adrenal glomerulosa cells. Am J Physiol. 1995;268. E135-E144.
18. Viard I, Jaillard C, Ouali R, Saez JM. Angiotensin-II-induced expression of proto-oncogene (c-fos, jun-B and c-jun) mRNA in bovine adrenocortical fasciculata cells (BAC) is mediated by AT-1 receptors. FEBS Lett. 1992;313:43-46.
19. Brownie AC, Gallant S, Nickerson PA, Joseph LM. The occurrence of 11-deoxycorticosterone (DOC)-induced hypertension in the Long-Evans rat. Endocr Res Commun. 1978;5:71-80.
20. Watanabe M, Honda M, Soma M, Minato M, Fukuda N, Watanabe Y, Izumi Y, Hatano M. Preventive effect of angiotensin I on weight reduction in the adrenal glands of DOCA/salt hypertensive rats. Endocrinol Jpn. 1990;37:521-528.
21. Wada T, Kanagawa R, Ishimura Y, Inada Y, Nishikawa K. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats. J Hypertens. 1995;13:113-122.
22. Kim S, Ohta K, Hamaguchi A, Omura T, Yukimura T, Miura K, Inada Y, Wada T, Ishimura Y, Chatani F, Iwao H. Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats. Hypertension. 1994;24:195-204.
23. Iwai N, Yamano Y, Chaki S, Konishi F, Bardhan S, Tibbetts C, Sasaki K, Hasegawa M, Matsuda Y, Inagami T. Rat angiotensin II receptor: cDNA sequence and regulation of the gene expression. Biochem Biophys Res Commun. 1991;177:299-304.
24. Kambayashi Y, Bardhan S, Takahashi K, Tsuzuki S, Inui H, Hamakubo T, Inagami T. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem. 1993;268:24543-24546.
25. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Ann Biochem. 1987;162:156-159.
26. Wilson SK, Lynch DR, Snyder SH. Angiotensin-converting enzyme labeled with [3H]captopril: tissue localizations and changes in different models of hypertension in the rat. J Clin Invest. 1987;80:841-851.
27. Miyamori I, Matsubara T, Takeda Y, Koshida H, Soma R, Takeda R. Angiotensin II generation in mesenteric arteries in rats: effects of nephrectomy, deoxycorticosterone and dexamethasone. Endocrinol Jpn. 1990;37:9-17.
28. Sessler FM, Kim SH, Malvin RL. Changes of renin isoelectric heterogeneity after acute and chronic stimulation of renin secretion. Proc Soc Exp Biol Med. 1986;182:258-262.
29. Michel B, Grima M, Stephan D, Coquard C, Welsch C, Barthelmebs M, Imbs JL. Plasma renin activity and changes in tissue angiotensin converting enzyme. J Hypertens. 1994;12:577-584.
30. Samani NJ, Brammar WJ, Swales JD. Renal and extra-renal levels of renin mRNA in experimental hypertension. Clin Sci (Colch). 1991;80:339-344.
31. Kanagy NL, Fink GD. Losartan prevents salt-induced hypertension in reduced renal mass rats. J Pharmacol Exp Ther. 1993;265:1131-1136.
32. Wang DH, Yao A, Zhao H, DiPette DJ. Regulation of ANG II receptor in hypertension: role of ANG II. Am J Physiol. 1996; 271(Heart Circ Physiol 40):H120-H125.
33. Ideishi M, Miura S, Sakai T, Maeda H, Kinoshita A, Sasaguri M, Jimi S, Arakawa K. Comparative effects of an angiotensin-converting enzyme inhibitor and an angiotensin II antagonist in Dahl rats. Blood Press Suppl. 1994;5:99-104.
34. Guo DF, Uno S, Ishihata A, Nakamura N, Inagami T. Identification of a cis-acting glucocorticoid responsive element in the ral angiotensin II type 1A promoter. Circ Res. 1995;77:249-257.
35. Douglas JG. Mechanism of adrenal angiotensin II receptor changes after nephrectomy in rats. J Clin Invest. 1981;67:1171-1176.
36. Lehoux JG, Bird IM, Rainey WE, Tremblay A, Ducharme L. Both low sodium and high potassium intake increase the level of adrenal angiotensin-II receptor type 1, but not that of adrenocorticotropin receptor. Endocrinology. 1994;134:776-782.
37. Pernollet MG, Devynck MA, Matthews PG, Meyer P. Post-nephrectomy changes in adrenal angiotensin II receptors in the rat: influence of exogenous angiotensin and a competitive inhibitor. Eur J Pharmacol. 1977;43:361-372.
38. Iwai N, Inagami T. Regulation of the expression of the rat angiotensin II receptor mRNA. Biochem Biophys Res Commun. 1992;182: 1094-1099.
39. Husain A, DeSilva P, Speth RC, Bumpus FM. Regulation of angiotensin II in rat adrenal gland. Circ Res. 1987;60:640-648.
40. Llorens-Cortes C, Greenberg B, Huang H, Corvol P. Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis. Hypertension. 1994;24:538-548.
41. Wang DH, Du Y. Distinct mechanisms of upregulation of type 1A angiotensin II receptor gene expression in kidney and adrenal gland. Hypertension. 1995;26(pt 2):1134-1137.
42. Regitz-Zagrosek V, Auch-Schwelk W, Hess B, Klein U, Duske E, Steffen C, Hildebrandt AG, Fleck E. Tissue- and subtype-specific modulation of angiotensin II receptors by chronic treatment with cyclosporin A, angiotensin-converting enzyme inhibitors and AT1 antagonists. J Cardiovasc Pharmacol. 1995;26:66-72.
43. Wakamiya R, Kohara K, Hiwada K. Gene expression of the type-1 angiotensin II receptor in rat adrenal gland. Blood Press Suppl. 1994;5:109-112.
44. Moreau P, Drolet G, Yamaguchi N, de Champlain J. Alteration of prejunctional alpha 2-adrenergic autoinhibition in DOCA-salt hypertension. Am J Hypertens. 1995;8:287-293.
45. Wang DH, Du Y. α1-Adrenoreceptor blockade enhances low salt-induced upregulation of type I angiotensin II receptor in adrenal gland. Hypertension. 1996;28:534. Abstract.